If you have a mechanical prosthetic heart valve, the FDA is warning patients not to use Pradaxa to treat atrial fibrillation. In fact, the FDA says that Pradaxa should not be used in patients who have atrial fibrillation caused by heart valve problems.
Watch out for studies testing the safety of pharmaceutical drugs when the studies are associated with the drug maker. In Sue Hughes's report on TheHeart.org, a study conducted by Trinity Partners Consultants found that Pradaxa was better than warfarin when it came to "persistence rates."
According to the American Bar Association Journal, lawyers have filed exactly 131 cases against Boehringer Ingelheim, the global drug maker based in Germany, and one of the largest pharmaceutical companies in the world. These suits allege that Boehringer Ingelheim's drug Pradaxa is a defective drug that has caused serious injuries and deaths among patients.
Sanjay Gupta, writing an opinion piece in the New York Times, suggests reasons why so many medical mistakes are said to occur in the nation. Gupta cites an estimate of roughly 200,000 patient deaths from medical mistakes every year, which would make it one of the leading causes of death.
A study shows that heart patients just might be putting themselves at greater risk by taking the pharmaceutical drug called Pradaxa, as compared to taking warfarin. ("Warfarin" is the generic name of a group of brand name drugs used in the treatment of heart disease.)